In a field where the laboratory notebook is still considered the state of the art, it’s no wonder a company like Benchling, which provides software for managing life sciences research, was able to nab ...

Ten years ago, Sajith Wickramasekara dropped out of the Computer Science program at MIT to build something new: a software company that helps life science researchers better organize their lab work.

Email and a smarter notebook might be enough for handling communication for projects or experiments inside a team in a lab in some university basement. But when you have around 200 scientists working ...

Sajith Wickramasekara started biotech R&D software company Benchling in his MIT dorm room. Now it's worth $850 million. Sajith Wickramasekara started working on an idea for a cloud-based Crispr design ...

SAN FRANCISCO--(BUSINESS WIRE)--Today Benchling, the data management and collaboration platform built to advance life sciences research, announced it has closed $14.5M in Series B funding. The round ...

SAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- Benchling, the platform for scientific progress, today announced a strategic collaboration with Lilly TuneLab, an artificial intelligence and machine ...

After picking up $200 million just over six months ago, Benchling isn’t sitting still. The cloud-based R&D platform developer collected another $100 million to help power its global expansion plans.

Benchling, the leading life sciences R&D cloud platform, today announced the launch of Benchling for Lab Automation, a new solution to help life sciences companies maximize lab automation investments.

Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...

SAN FRANCISCO--(BUSINESS WIRE)--Benchling, Inc., a leading developer of cloud-based tools for life science, today announced the launch of its new platform which accelerates R&D by tracking experiment ...

Investors are eager for the Benchling IPO. The company made headlines when it confidentially filed with the SEC to go public. Biotechnology is rewriting life as we know it. Our customers, spanning ...